↓ Skip to main content

Aminaphtone Efficacy in Primary and Secondary Raynaud’s Phenomenon: A Feasibility Study

Overview of attention for article published in Frontiers in Pharmacology, April 2019
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (68th percentile)
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter
11 X users
facebook
1 Facebook page

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
18 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Aminaphtone Efficacy in Primary and Secondary Raynaud’s Phenomenon: A Feasibility Study
Published in
Frontiers in Pharmacology, April 2019
DOI 10.3389/fphar.2019.00293
Pubmed ID
Authors

Barbara Ruaro, Carmen Pizzorni, Sabrina Paolino, Elisa Alessandri, Alberto Sulli

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 3 17%
Student > Master 2 11%
Researcher 2 11%
Student > Ph. D. Student 2 11%
Unspecified 1 6%
Other 2 11%
Unknown 6 33%
Readers by discipline Count As %
Medicine and Dentistry 6 33%
Immunology and Microbiology 2 11%
Unspecified 1 6%
Agricultural and Biological Sciences 1 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Other 2 11%
Unknown 5 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 September 2023.
All research outputs
#6,587,547
of 25,820,938 outputs
Outputs from Frontiers in Pharmacology
#2,865
of 20,020 outputs
Outputs of similar age
#113,664
of 365,960 outputs
Outputs of similar age from Frontiers in Pharmacology
#107
of 346 outputs
Altmetric has tracked 25,820,938 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 20,020 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,960 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 346 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.